Cost Effectiveness of Fluticasone Propionate Plus Salmeterol Versus Fluticasone Propionate Plus Montelukast in the Treatment of Persistent Asthma

Author： Richard D. OConnor

Publisher： Adis International

ISSN： 1170-7690

Source： PharmacoEconomics, Vol.22, Iss.12, 2004-01, pp. : 815-825

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cost-Effectiveness Comparison of Salmeterol/Fluticasone Propionate versus Montelukast in the Treatment of Adults with Persistent Asthma

By Sheth K.

PharmacoEconomics, Vol. 20, Iss. 13, 2002-01 ,pp. : 909-918

Adis International

Access to resources Recommend Favorite

Cost Effectiveness of Budesonide/Formoterol for Maintenance and Reliever Therapy versus Salmeterol/Fluticasone plus Salbutamol in the Treatment of Asthma

By Johansson Gunnar

PharmacoEconomics, Vol. 24, Iss. 7, 2006-01 ,pp. : 695-708

Adis International

Access to resources Recommend Favorite

Cost-Effectiveness and Cost-Utility of Beclomethasone/Formoterol versus Fluticasone Propionate/Salmeterol in Patients with Moderate to Severe Asthma

By Gerzeli Simone

Clinical Drug Investigation, Vol. 32, Iss. 4, 2012-04 ,pp. : 253-265

Adis International

Access to resources Recommend Favorite

Salmeterol/fluticasone propionate cost effective in asthma

Inpharma, Vol. 1, Iss. 1219, 2000-01 ,pp. : 10-10

Adis International

Access to resources Recommend Favorite

Salmeterol/fluticasone propionate cost effective in asthma

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 358, 2002-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite